Clinical Trial

MRI-guided Ultrahypofractionated SBRT Prostate Program

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the use of MRI-guided asymmetric ultrahipofractionated irradiation (2 fractions with dose increase in the tumor areas and dose sparing in urethra, rectum and neurovascular bundles) produces similar results in terms of local control and complications to standard 5-fraction SBRT.
Trial Details
NCT Number NCT07132658
Lead Sponsor Clinica Universidad de Navarra, Universidad de Navarra
Conditions Prostate Cancer
Enrollment 40 participants
Start Date 2025-10-01
Primary Completion 2030-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-20